Per the Elmira Star-Gazette: Dr. Robert Masson has realistic hopes of winning a championship this season in IMSA’s Prototype Challenge Presented by Mazda series. Although those cars are sitting this weekend … Continue Reading Centinel Spine in the News: Renowned neurosurgeon, racer Dr. Robert Masson carries health message to IMSA
New York, NY, June 14, 2018 – Centinel Spine, LLC is pleased to announce that TRICARE, the Military Health System for almost 10 million beneficiaries world-wide, has updated its coverage policy … Continue Reading Centinel Spine Announces Lumbar Total Disc Replacement coverage by TRICARE
New York, NY, June 7, 2018 – Centinel Spine, LLC is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its … Continue Reading Centinel Spine Announces 510(k) Clearance of FLX™ Platform of 3D Printed All-Titanium Interbodies
New York, NY, March 20, 2018 – Centinel Spine, LLC is pleased to announce that it has entered into an endorsement agreement with four time PGA Tour Winner, Brian Gay. … Continue Reading Centinel Spine Announces Partnership with PGA Tour Winner Brian Gay
New York, NY, February 14, 2018 – Centinel Spine, LLC is pleased to announce that it has extended an endorsement agreement with Performance Tech Motorsports for the entirety of the … Continue Reading Centinel Spine and Performance Tech Announce Plan for a Season of Success!
DEERFIELD BEACH, Fla. (Jan. 16, 2018) – Performance Tech Motorsports is teaming up with Centinel Spine for the Rolex 24 At Daytona with an effort to bring together two technological leaders with the IMSA WeatherTech SportsCar Championship. … Continue Reading Performance Tech Teams with Centinel Spine for Rolex 24
New York, NY, December 21, 2017 – Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy … Continue Reading Centinel Spine Announces the Acquisition of the Worldwide Assets of the prodisc Total Disc Replacement Portfolio
New York, NY, June 23, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of the No- Profile, Integrated Interbody™ fusion device market, is granted clearance for STALIF L™ No- … Continue Reading Centinel Spine® Granted Australian Clearance for STALIF L™ Minimally-Invasive, Lateral Integrated Interbody™ System
New York, NY, June 21, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of the No-Profile®, Integrated Interbody™ fusion device market, completes Alpha release of STALIF L™ No-Profile, lateral … Continue Reading Centinel Spine® Completes Successful Evaluation of STALIF L™ Minimally-Invasive Lateral Integrated Interbody System
New York, NY, May 26, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, launches MIDLINE II-Ti™, a Ti-ACTIVE™ coated, No-Profile, anterior lumbar Integrated Interbody … Continue Reading Centinel Spine® Launches MIDLINE II-Ti™ in Australia
New York, NY, May 24, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti™ product family, a Ti-ACTIVE™-coated, No-Profile, … Continue Reading Centinel Spine® Expands STALIF® Internationally
NEW YORK, Jan. 21, 2016 — Centinel Spine, Inc., (Centinel Spine) announces the U.S. Food and Drug Administration (FDA) clearance of ALTOS™, a posterior cervical thoracic stabilization system indicated for use in … Continue Reading Centinel Spine® Announces the FDA Clearance and First Implantation of ALTOS™
New York, NY, July 28, 2015 – Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices implants its first two STALIF® MIDLINE II-Ti™ devices at … Continue Reading Centinel Spine® Implants Its First STALIF® MIDLINE II-Ti™ Device
New York, NY, June 30, 2015 – Centinel Spine, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone … Continue Reading Centinel Spine® is Granted the First Cervical Multilevel Indication for Its STALIF C® Integrated Interbody™ Device
New York, NY, June 16, 2015 – Centinel Spine®, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices receive FDA clearance for its STALIF MIDLINE®, MIDLINE II™, MIDLINE II-Ti™ (Ti–ACTIVE™) … Continue Reading Centinel Spine® Receives Allogeneic Bone Graft Indication For Its Anterior Lumbar Product Family
New York, NY: June 1, 2015 – Centinel Spine, Inc. (Centinel Spine), the pioneer of spinal Stand-Alone, No-Profile®, Integrated Interbody™ devices has now implanted 20,000 STALIF C cervical Integrated Interbody … Continue Reading Centinel Spine® Passes 20,000 Implant Milestone with STALIF C® Cervical Integrated Interbody™ Devices